Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This is an open label randomized phase II trial of maintenance oral etoposide vs. observation
in patinets with relapsed GCT treated with high-dose chemotherapy (HDCT) and peripheral-blood
stem-cell transplant (PBSCT).